Literature DB >> 12887167

The prevalence of GP Mur and anti-"Mia" in a tertiary hospital in Peninsula Malaysia.

Ramesh Prathiba1, C G Lopez, F Mary Usin.   

Abstract

The Mi III phenotype of the Miltenberger subsystem (or GP Mur) is relatively common in Southeast Asia especially along the south-east coast lines of China and Taiwan. The term anti-"Mia" describes antibodies that react with the Mi III phenotype. Since the Peninsula Malaysian population is a multiethnic one with a significant proportion of Chinese, a study was conducted into the prevalence of anti-"Mia" in patients from its 3 major ethnic groups--Chinese, Malays and Indians, as well as the GP Mur phenotype in blood donors (healthy individuals). Blood samples from 33,716 patients (general and antenatal) were screened for anti-"Mia" from January 1999 to December 2000. The investigation for the GP Mur phenotype representing the corresponding sensitizing antigen complex was carried out in 655 blood donors. Serum anti-"Mia" antibody was found to be the third most commonly occurring antibody detected in our patients and was found in all the ethnic groups. The antibody was detected in 0.2% of 33,716 antenatal and general patients with a prevalence in Chinese of 0.3%, Malay 0.2% and Indian 0.2%. The detection of these antibodies in the ethnic groups other than the Chinese is a noteworthy finding as such information is not well documented. The GP Mur red cell phenotype was detected in 15/306 (4.9%) of Chinese blood donors, a lower prevalence than in Chinese populations in other countries in the region. More significant was its detection in the Malays (2.8%) and the Indians (3.0%). Because of the many reports of clinical problems associated with the "Mia" antibody including the causation of fetal hydrops and haemolytic transfusion reactions, it is warranted that the GP Mur red cells be included in screening panels for group and screen procedures in countries with a significant Asian population.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12887167

Source DB:  PubMed          Journal:  Malays J Pathol        ISSN: 0126-8635            Impact factor:   0.656


  7 in total

1.  Incidence of Red Cell Alloantibody among the Transfusion Recipients of Universiti Kebangsaan Malaysia Medical Centre.

Authors:  Rabeya Yousuf; Suria Abdul Aziz; Nurasyikin Yusof; Chooi Fun Leong
Journal:  Indian J Hematol Blood Transfus       Date:  2012-04-25       Impact factor: 0.900

Review 2.  Blood Groups in Infection and Host Susceptibility.

Authors:  Laura Cooling
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

3.  Frequency of Mia (MNS7) and Classification of Mia-Positive Hybrid Glycophorins in an Australian Blood Donor Population.

Authors:  Genghis H Lopez; Brett Wilson; Robyn M Turner; Glenda M Millard; Nicole S Fraser; Naomi M Roots; Yew-Wah Liew; Catherine A Hyland; Robert L Flower
Journal:  Transfus Med Hemother       Date:  2019-11-14       Impact factor: 3.747

4.  The external quality assessment scheme: Five years experience as a participating laboratory.

Authors:  Rajendra Chaudhary; Sudipta S Das; Shashank Ojha; Dheeraj Khetan; Atul Sonker
Journal:  Asian J Transfus Sci       Date:  2010-01

5.  Detection of alloimmunization to ensure safer transfusion practice.

Authors:  Rashmi Sood; R N Makroo; Vimarsh Riana; N L Rosamma
Journal:  Asian J Transfus Sci       Date:  2013-07

6.  Type and screen policy in the blood bank: Is AHG cross-match still required? A study at a multispecialty corporate hospital in India.

Authors:  Sangeeta Pathak; M Chandrashekhar; G R Wankhede
Journal:  Asian J Transfus Sci       Date:  2011-07

7.  Outcome of type and screen versus crossmatch in cardiovascular surgery patients: A comparative study.

Authors:  Anupa Pokhrel; Ashish Jain; Neelam Marwaha; Rana Sandip Singh
Journal:  Asian J Transfus Sci       Date:  2022-05-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.